GLPHubglpresearchhub.com
Read-only archive. GLP Research Hub is a static community record — nothing here is for sale, no account is needed, and no vote you cast is counted. Why?
Single comment threadYou are looking at one branch of why does nobody talk about denial — 36 comments in the full submission. View in context.
2.7k
c/insurancefights·submitted 9 months ago by u/neha_rahimi

why does nobody talk about denial

Appealbranch of 8 comments

Question in the title, detail here: why does nobody talk about denial. New plan year, entirely new criteria, and the denial that had been immovable in the autumn simply did not apply in January. The process that has actually worked for people on this board, in order. Get the denial in writing and find the criterion…

Read the full submission and all 36 comments →

This branch

8 comments, started 9 months ago
u/tomas_lehtinen155 points·9 months ago

Prior authorisation criteria are republished each plan year. A criterion that blocked you in one year may not exist in the next, so a denial is worth retesting after the turnover.

replysharereportpermalink
u/hplc_hobbyistruns their own column52 points·9 months ago

prior authorisation criteria change every plan year

replysharereportpermalink
u/sofia_ferreira39 points·9 months ago

prior authorisation criteria change every plan year

hplc_hobbyist is right that this is documentation rather than persuasion. It took me a year to accept that.

replysharereportpermalink
u/vito_beaulieu32 points·9 months ago

Correction: that is a formulary exclusion, not a prior authorisation denial. Different form, different route, different deadline.

replysharereportpermalink
u/tuva_aalto-30 points·9 months ago

Appeal deadlines run from the date on the determination letter. They are strict, they are short, and a missed deadline usually forfeits that level entirely.

replysharereportpermalink
u/elin_lindqvist1 point·9 months ago

Employer-sponsored plans may be regulated differently from individually purchased ones, which changes both the appeal route and which regulator hears a complaint.

replysharereportpermalink
[removed]1 point·9 months ago

[removed by moderator]

replysharereportpermalink
u/rekha_vestergaard64 points·9 months ago·edited

I would not skip the peer-to-peer. It is often the fastest route and it costs a phone call.

replysharereportpermalink

← back to the whole thread

About c/insurancefights

The paperwork war. Prior-authorisation criteria, denial reason codes, step-therapy documentation, external review, employer carve-outs, and the appeal letter templates the community has iterated on for three years. Mostly US-shaped but the tactics generalise.

46kmembers
95submissions
Dec 2023created
submissions / month, last year
Sponsored

Sigma-Aldrich Standards

Certified reference materials for peptide identity and purity work.

sigmaaldrich.com
c/insurancefights rules
  1. Say which country and which plan type. "Insurance" means eleven different things.
  2. Redact member ids and group numbers from every screenshot.
  3. Do not suggest misrepresenting a diagnosis. That is fraud and it gets you banned.
  4. Independent community. Nobody here sells anything, and anyone who tries is banned.
  5. Not medical advice. Describe what you did; never prescribe to a stranger.
  6. Claims need evidence. Batch numbers, dated screenshots, independent test reports, or a citation.
  7. No referral links, discount codes or affiliate URLs. Permanent ban, no appeal.
  8. No contact handles, wallet addresses or tracking numbers — they identify people.
  9. Be recognisably decent. Disagree hard, insult nobody.
Moderators
Volunteers. Unpaid, unaffiliated, and reachable through modmail only.
Before you read on

Several compounds discussed on GLP Research Hub are sold for research use only and are not approved for human use anywhere. Nothing here is medical advice and none of it is written by your clinician. If a post reads like an instruction, treat it as a description of what one stranger did.